Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
Stanford University
Stanford University
Mayo Clinic
Vanderbilt-Ingram Cancer Center
University of Iowa
University of Southern California
Yale University